Journal: Oncology Letters

Article Title: Triple-negative invasive lobular carcinoma presenting with synchronous gastric metastasis: A case report

doi: 10.3892/ol.2025.15242

Figure Lengend Snippet: Immunohistochemistry results of the gastric biopsy specimen (magnification, ×100). (A) ER, (B) HER-2, (C) CK7, (D) GATA-3, (E) Villin and (F) CK20. ER, estrogen receptor; PR, progesterone receptor; CK, cytokeratin; GATA-3, GATA binding protein 3.

Article Snippet: The primary antibodies used included: ER (cat. no. ZA0102), PR (cat. no. ZA-0255), HER-2 (cat. no. ZM-0065), E-cadherin (cat. no. ZA-0565), Ki-67 (cat. no. ZM-0166), CK5/6 (cat. no. ZM-0313), CK14 (cat. no. ZA-0540), AR (cat. no. ZA-0554), GATA-3 (cat. no. ZA-0661), CK7 (cat. no. ZM-0071), CK20 (cat. no. ZA-0574) and Villin (cat. no. ZM-0261), all from Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd. (OriGene Technologies, Inc.) and supplied at a ready to use dilution.

Techniques: Immunohistochemistry, Binding Assay

Journal: Oncology Letters

Article Title: Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review

doi: 10.3892/ol.2024.14633

Figure Lengend Snippet: Right ovary with metastatic low-grade appendiceal mucinous neoplasm. Immunohistochemical staining for (A) caudal type homeobox 2, (B) cytokeratin 20 and (C) paired box gene 8. Magnification, ×100.

Article Snippet: Antigen retrieval by microwave and blocking of endogenous peroxidase activity (by 1% hydrogen peroxide in distillated water for 10 min at room temperature) was conducted before incubation with the following primary antibodies: CK20 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA777; DAKO; Agilent Technologies, Inc.), CDX2 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA080; DAKO; Agilent Technologies, Inc.) and PAX8 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. 760-4618; Roche Diagnostics) at 4°C overnight.

Techniques: Immunohistochemical staining, Staining

Journal: Oncology Letters

Article Title: Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review

doi: 10.3892/ol.2024.14633

Figure Lengend Snippet: Expression patterns of the most common immunohistochemistry markers depending on the origin of the tumor.

Article Snippet: Antigen retrieval by microwave and blocking of endogenous peroxidase activity (by 1% hydrogen peroxide in distillated water for 10 min at room temperature) was conducted before incubation with the following primary antibodies: CK20 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA777; DAKO; Agilent Technologies, Inc.), CDX2 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA080; DAKO; Agilent Technologies, Inc.) and PAX8 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. 760-4618; Roche Diagnostics) at 4°C overnight.

Techniques: Expressing, Immunohistochemistry

Journal: Oncology Letters

Article Title: Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review

doi: 10.3892/ol.2024.14633

Figure Lengend Snippet: Expression patterns of concomitant IHC markers in POMN and APE.

Article Snippet: Antigen retrieval by microwave and blocking of endogenous peroxidase activity (by 1% hydrogen peroxide in distillated water for 10 min at room temperature) was conducted before incubation with the following primary antibodies: CK20 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA777; DAKO; Agilent Technologies, Inc.), CDX2 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA080; DAKO; Agilent Technologies, Inc.) and PAX8 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. 760-4618; Roche Diagnostics) at 4°C overnight.

Techniques: Expressing